Brooke Drew, PA
Medical · Fort Myers, FLNPI 1477830669
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,285 of the $3,655 with a category attached, or 89.9%. It is spread thinly across 21 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,406, more than ten times the $22 reported in 2021.
Across 166 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$626
- AbbVie$460
- Pfizer$306
- Sun Pharmaceutical Industries Inc.$304
- Sanofi$294
- E.r. Squibb & Sons, L.L.C.$256
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,28590%
- Education$37010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 28 | $626 |
| AbbVie(2 entities) | 29 | $460 |
| Pfizer | 15 | $306 |
| Sun Pharmaceutical Industries Inc. | 14 | $304 |
| Sanofi | 9 | $294 |
| E.r. Squibb & Sons, L.L.C. | 13 | $256 |
| Regeneron Healthcare Solutions, Inc. | 6 | $219 |
| Lilly USA, LLC | 7 | $182 |
| Incyte Corporation | 7 | $176 |
| Novartis | 8 | $171 |
| Arcutis Biotherapeutics, Inc. | 8 | $154 |
| UCB, Inc. | 3 | $106 |
| Amgen | 4 | $97 |
| Dermavant Sciences, Inc. | 3 | $54 |
| LEO Pharma Inc. | 2 | $53 |
| Revance Therapeutics, Inc. | 2 | $51 |
| Strata Skin Sciences, Inc. | 3 | $50 |
| Galderma Laboratories, L.p. | 2 | $39 |
| Biofrontera Inc. | 1 | $22 |
| Almirall LLC | 1 | $19 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
How this compares
$3,655 in reported general payments places this provider in the 80th percentile of 2,031 medical providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 14 | $99,625 |
| Clobetasol Propionate | 121 | $5,483 |
| Ketoconazole | 166 | $3,034 |
| Fluorouracil | 36 | $2,632 |
| Metronidazole | 42 | $1,928 |
| Triamcinolone Acetonide | 162 | $1,568 |
| Clindamycin Phosphate | 48 | $1,293 |
| Doxycycline Hyclate | 86 | $1,256 |
| ValacyclovirValacyclovir Hcl | 33 | $885 |
| Ciclopirox | 20 | $641 |
| Imiquimod | 21 | $496 |
| Hydrocortisone | 101 | $435 |
| Mupirocin | 38 | $287 |
| Fluocinonide | 11 | $278 |
| Nystatin | 19 | $260 |
Paid to pharmacies, not to this prescriber.
Other medical in Fort Myers
- Kailen GonzalezFort Myers$29K
- Demi SouletFort Myers$15K
- Gary RubinRockledge$2.1M
- Shanna MirantiNaples$415K
- Krystie LennoxBoca Raton$245K
- Jihan RamadanWellington$238K
- Ilanit SamuelsMiami$211K
- Erin DouceyWinter Haven$202K
- Kathleen TrummerWellington$166K
- Sandra SnyderTampa$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.